Arthritis Completed Phase 3 Trials for Tapentadol (DB06204)

Also known as: Articular inflammation / Unspecified osteoarthritis, unspecified site / Inflammatory arthritis / Arthritis (disorder) / Arthritis NOS

IndicationStatusPhase
DBCOND0016433 (Arthritis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00784277A Study to Compare the Frequency of Constipation Symptoms With Tapentadol Immediate Release (IR) Treatment Versus Oxycodone IR Treatment in Patients With End-stage Joint DiseaseTreatment